Table 1. Treatment with MIA-602 on Doxorubicin-resistant K-562 tumors results in decreased weight and volume after 28 days.
| Final tumor weight (mg) | Final tumor volume (mm3) | |
|---|---|---|
| K-562 Control | 1512 ± 88 | 1114 ± 71 |
| K-562 Treated | 890 ± 59.5 | 629 ± 48.3 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.